Literature DB >> 11246099

Elevated plasma nitrate levels in depressive states.

E Suzuki1, G Yagi, T Nakaki, S Kanba, M Asai.   

Abstract

BACKGROUND: Previous studies have shown that nitric oxide (NO) synthase inhibitors show preclinical antidepressant-like properties, suggesting that NO is involved in the pathogenesis of depression. The purpose of this study is to examine whether or not NO production increases in depressed patients.
METHODS: Plasma nitrate concentrations, an index of NO production, were measured by high-performance liquid chromatography in depressed patients (n=17) and compared with patients suffering anxiety (n=6) and with healthy controls (n=12).
RESULTS: Plasma nitrate concentrations were significantly higher in depressed patients than in patients with an anxiety disorder (P<0.05) or in controls (P<0.01). LIMITATIONS: The study group was small. The source of the surplus production of NO in patients with major depressive episode remains unclear.
CONCLUSIONS: These results suggest that NO production is increased in depression.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11246099     DOI: 10.1016/s0165-0327(00)00164-6

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  42 in total

1.  Atorvastatin and Fluoxetine Prevent Oxidative Stress and Mitochondrial Dysfunction Evoked by Glutamate Toxicity in Hippocampal Slices.

Authors:  Fabiana K Ludka; Tharine Dal-Cim; Luisa Bandeira Binder; Leandra Celso Constantino; Caio Massari; Carla I Tasca
Journal:  Mol Neurobiol       Date:  2016-04-06       Impact factor: 5.590

2.  Lithium increases nitric oxide levels in subjects with bipolar disorder during depressive episodes.

Authors:  Rafael T de Sousa; Marcus V Zanetti; Geraldo F Busatto; Margaret G Mouro; Carlos A Zarate; Wagner F Gattaz; Elisa M Higa; Rodrigo Machado-Vieira
Journal:  J Psychiatr Res       Date:  2014-04-12       Impact factor: 4.791

3.  Side effects of interferon-alpha therapy.

Authors:  Stefan Sleijfer; Marjolein Bannink; Arthur R Van Gool; Wim H J Kruit; Gerrit Stoter
Journal:  Pharm World Sci       Date:  2005-12

4.  Neuronal NOS inhibitor and conventional antidepressant drugs attenuate stress-induced fos expression in overlapping brain regions.

Authors:  Michelle Silva; Daniele C Aguiar; Cassiano R A Diniz; Francisco Silveira Guimarães; Sâmia R L Joca
Journal:  Cell Mol Neurobiol       Date:  2011-11-27       Impact factor: 5.046

5.  Psychopharmacology of maternal separation anxiety in vervet monkeys.

Authors:  Lelanie Marais; Willie Daniels; Linda Brand; Francois Viljoen; Charmaine Hugo; Dan J Stein
Journal:  Metab Brain Dis       Date:  2006-07-19       Impact factor: 3.584

6.  NMDA receptor/nitrergic system blockage augments antidepressant-like effects of paroxetine in the mouse forced swimming test.

Authors:  Mehdi Ghasemi; Laleh Montaser-Kouhsari; Hamed Shafaroodi; Behtash Ghazi Nezami; Farzad Ebrahimi; Ahmad Reza Dehpour
Journal:  Psychopharmacology (Berl)       Date:  2009-07-16       Impact factor: 4.530

7.  Inhibition of neuronal nitric oxide synthase in the rat hippocampus induces antidepressant-like effects.

Authors:  Sâmia Regiane Lourenço Joca; Francisco Silveira Guimarães
Journal:  Psychopharmacology (Berl)       Date:  2006-03-01       Impact factor: 4.530

Review 8.  A Review of Biomarkers in Mood and Psychotic Disorders: A Dissection of Clinical vs. Preclinical Correlates.

Authors:  Sarel J Brand; Marisa Moller; Brian H Harvey
Journal:  Curr Neuropharmacol       Date:  2015       Impact factor: 7.363

9.  DETA/NONOate, a nitric oxide donor, produces antidepressant effects by promoting hippocampal neurogenesis.

Authors:  Yao Hua; Xin-Yan Huang; Li Zhou; Qi-Gang Zhou; Yao Hu; Chun-Xia Luo; Fei Li; Dong-Ya Zhu
Journal:  Psychopharmacology (Berl)       Date:  2008-05-30       Impact factor: 4.530

10.  Long-term imipramine treatment increases nitrate levels in the rat hypothalamus.

Authors:  Eiji Suzuki; Toshio Nakaki; Shigenobu Kanba; Futoshi Shintani; Hitoshi Miyaoka
Journal:  Cell Mol Neurobiol       Date:  2003-12       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.